Photo courtesy of 42 Technology Limited

Thank you!

Thanks to your participation, nearly 41,000 babies have been included in the DIvO study. We have learnt a lot about what works well and what doesn’t using the current device prototype, and this will help us to make an even better device to help babies in the UK and overseas, allowing early detection of cataract and prevention of sight loss.

Findings so far..

Our data so far shows that several cataracts - like the one shown here - were not detected using the standard screening test, but were detected with Neocam. An overwhelming majority of screeners also preferred to use Neocam compared to the standard test. To be able to fully compare the accuracy of the two methods, we will need to wait until early 2027 when all the babies we recruited have all turned one year old. When we have analysed the results, the study findings will be available here on the website.

Your data

If you have previously enrolled for the study, we will continue to store your contact details and NHS number in the secure trial system database. This data may be used for analysis but any identifying information will be removed. Your name, NHS number and email will be stored by Cambridge University Hospitals NHS Trust (CUH) only for the duration of the study and will not be used for any other purpose. Your details will not be shared with any third parties. For further information on how CUH protects your data please see the CUH data and privacy information page.